University of California-San Francisco: Microbiome Therapy Protects Against Recurrent Bacterial Vaginosis
May 14, 2020
May 14, 2020
SAN FRANCISCO, California, May 14 -- The University of California San Francisco campus issued the following news release:
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
Bacterial vaginosis is one of the most frequent bacterial infections, affecting nearly 30 percent of women o . . .
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
Bacterial vaginosis is one of the most frequent bacterial infections, affecting nearly 30 percent of women o . . .